Lawmaker calls for tax waiver over rare disease treatments

A lawmaker has proposed a revised bill that that the government should implement steps to waiver import duties and value added taxes levied on a medicine that treats a rare disease, such as Elaprase (idursulfase), Naglyzyme (galsulfase) and homocystinuria treatments.

“Taxes imposed on such treatments are quite burdensome to patients and their family members. We want a waiver in the number of...